Drug · DIN 02512947
COVISHIELD
VIAL CONTAINS 10 DOSES OF 0.5 ML
No: authorization expired
Was authorized under an interim order; the authorization expired.
Status Authorization By Interim Order Expired since September 16, 2021; first marketed March 3, 2021.
- Drug Identification Number (DIN)
- 02512947
- Company (DIN owner)
- Verity Pharmaceuticals IncToronto, Ontario, Canada
- Schedule
- Covid-19 - io - authorization; Schedule d
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Covid-19, viral vector, non-replicating J07BN02
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CHADOX1-S [RECOMBINANT] | 50000000000 VP | 0.5 ML |
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “covishield”. A notice may cover another product or only some lots: read it to see what it covers.
- AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak SyndromeJune 29, 2021 · Biologic or vaccine · COVID - Product safety
- AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with ThrombocytopeniaMarch 24, 2021 · Biologic or vaccine · COVID - Product safety